Advertisement

Topics

HCC De Facto Group plc Company Profile

16:25 EST 21st November 2017 | BioPortfolio

Public Relations and communications in the life sciences.

Location

No 1 London Wall Buildings, London Wall
London
Greater London
EC2M 5PG
United Kingdom

Contact

Phone: 020 7496 3300
Fax: 020 7496 3355


News Articles [284 Associated News Articles listed on BioPortfolio]

Islamic State group loses emblematic Syria stronghold Raqa

US-backed forces took full control of Raqa from the Islamic State group on Tuesday, defeating the last jihadist holdouts in the de facto Syrian capital of their now-shattered "caliphate". The victory...

US-backed forces breach wall in Syria IS stronghold Raqa

US-backed forces in Syria have entered the most heavily fortified area of Raqa, the de facto capital of the Islamic State group, in what a US official says is a "key milestone" in the war against the ...

Where’s Rex?

U.N. Ambassador Nikki Haley steps in as America’s de facto diplomat-in-chief.

Defeat of Islamic State in Raqqa may herald wider struggle for U.S.

By Arshad Mohammed and Yara Bayoumy WASHINGTON (Reuters) - The defeat of Islamic State in its de facto capital Raqqa may only be the start of a wider struggle by the United States to contain any insu...

US-backed Syrian fighters now control almost half of IS city

RAQQA, Syria (AP) — Heavy fighting broke out Thursday as U.S.-backed Syrian fighters captured almost half of the Islamic State group's de facto capital of Raqqa. But the push into the city in no...

Malala Has Powerful Message For Myanmar Leader: Condemn 'Tragic' Rohingya Violence

Activist Malala Yousafzai has issued a powerful statement urging “my fellow Nobel Laureate Aung San Suu Kyi,” Myanmar’s de facto leader, to do something about the humanitarian crisis unfolding ...

Fighters in Syria's Raqa prepare for civilian handover

US-backed forces who captured Raqa from the Islamic State group prepared to hand the Syrian city over to a civilian authority, with some of their fighters already headed to the next battle. Inside th...

Iraq declares end of caliphate after capture of Mosul mosque

By Khaled al-Ramahi and Maher Chmaytelli MOSUL/ERBIL, Iraq (Reuters) - After eight months of grinding urban warfare, Iraqi government troops on Thursday captured the ruined mosque at the heart of Isl...

PubMed Articles [1807 Associated PubMed Articles listed on BioPortfolio]

Untangling outcomes of de jure and de facto community-based management of natural resources.

We systematically reviewed the literature on the tragedy of the commons and common-property resources. We segregated studies by legal management regimes (de jure regimes) and management that develops ...

Transcanalicular laser-assisted dacryocystorhinostomy with diode laser.

This article compares the efficacy of transcanalicular laser assisted dacryocystorhinostomy (TL DCR) with conventional external dacryocystorhinostomy (Ex DCR). All patients were randomly divided into ...

Quantifying pathogen risks associated with potable reuse: A risk assessment case study for Cryptosporidium.

This study evaluated the reliability and equivalency of three different potable reuse paradigms: (1) surface water augmentation via de facto reuse with conventional wastewater treatment; (2) surface w...

Thirty first annual symposium on etiology, pathogenesis, and treatment of Parkinson disease and other movement disorders: Presented by the Parkinson study group, huntington study group, dystonia study group, tourette syndrome study group, cooperative ataxia group, and tremor research group.

Protective effects of Tempol in an experimental ovarian ischemia-reperfusion injury model in female Wistar Albino rats.

The aim of this study was to investigate the antioxidant effects of tempol on ovarian ischemia-reperfusion injury in rats. Forty female Wistar albino rats were randomly divided into five groups: Group...

Clinical Trials [3248 Associated Clinical Trials listed on BioPortfolio]

FACTO Study (Foster® As Complete Treatment Option)

Double blind, multinational, multicentre, randomised, 2 arm parallel group study

A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-Based Therapy

Although initially responsive to cytoreductive surgery and platinum- and/or taxane-based chemotherapy, a majority of patients with epithelial ovarian cancer, cancer of the fallopian tube o...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

Companies [1583 Associated Companies listed on BioPortfolio]

De Facto Communications

De Facto Communications is one of Europe's most successful public relations consultancies in the fields of life science, healthcare, medical education and clinical trials. In partnership with our clie...

HCC De Facto Group plc

Public Relations and communications in the life sciences.

De Facto communication ltd

Nil

Acesis

Headquartered in Silicon Valley, Acesis (ă'sē-sĭs) is an enterprise software company providing hospitals and hospital systems with products that help improve quality and ...

DataMetrix

Co-founded in 2005 by Mary Jane LaBelle and Brent Anderson, DataMetrix provides medical auditing, post payment review and data mining services. LaBelle, a pioneer in the developme...

More Information about "HCC De Facto Group plc" on BioPortfolio

We have published hundreds of HCC De Facto Group plc news stories on BioPortfolio along with dozens of HCC De Facto Group plc Clinical Trials and PubMed Articles about HCC De Facto Group plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of HCC De Facto Group plc Companies in our database. You can also find out about relevant HCC De Facto Group plc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record